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ABSTRACT
Background Policy is shaped and influenced by a diverse 
set of stakeholders at the global, national and local levels. 
While stakeholder analysis is a recognised practical 
tool to assess the positions and engagement of actors 
relevant to policy, few empirical studies provide details 
of how complex concepts such as power, interest and 
position are operationalised and assessed in these types of 
analyses. This study aims to address this gap by reviewing 
conceptual approaches underlying stakeholder analyses 
and by developing a framework that can be applied to 
policy implementation in low- and- middle income countries.
Methods The framework was developed through a three- 
step process: a scoping review, peer review by health 
policy experts and the conduct of an analysis using key 
informant interviews and a consensus building exercise. 
Four characteristics were selected for inclusion: levels of 
knowledge, interest, power and position of stakeholders 
related to the policy.
Result The framework development process highlighted 
the need to revisit how we assess the power of actors, 
a key issue in stakeholder analyses, and differentiate an 
actor’s potential power, based on resources, and whether 
they exercise it, based on the actions they take for or 
against a policy. Exploration of the intersections between 
characteristics of actors and their level of knowledge can 
determine interest, which in turn can affect stakeholder 
position on a policy, showing the importance of analysing 
these characteristics together. Both top- down and 
bottom- up approaches in implementation must also be 
incorporated in the analysis of policy actors, as there are 
differences in the type of knowledge, interest and sources 
of power among national, local and frontline stakeholders.
Conclusion The developed framework contributes to 
health policy research by offering a practical tool for 
analysing the characteristics of policy actors and tackling 
the intricacies of assessing complex concepts embedded 
in the conduct of stakeholder analyses.
INTRODUCTION
Researchers seeking to influence policy must 
engage with relevant stakeholders. But whom 
and how? Stakeholder analysis can identify 
key actors in the policy process and develop 
strategies to engage with them.1 Stakeholders 
are defined by Varvasovszky and Brugha as 
“actors who have an interest in the issue under 
consideration, who are affected by the issue, 
or who – because of their position – have or 
could have an active or passive influence on 
the decision- making and implementation 
processes.”2
Stakeholder analysis can be used for 
different purposes in policy research, 
Key questions
What is already known?
 ► Stakeholder analyses require assessment of the lev-
els of power, position and interest of actors relative 
to health policies, but few empirical studies provide 
details of how the complex concepts embedded 
within these analyses are operationalised.
What are the new findings?
 ► There is no universally agreed way of conducting 
stakeholder analyses, as different studies followed 
diverse guidelines and frameworks and operation-
alised key concepts such as stakeholder power and 
interest in various ways.
 ► The developed framework proposes to assess stake-
holder power as potential power in terms of access 
to resources, and position to reflect an actor’s actu-
al exercise of power based on actions taken for or 
against a policy. Intersections between knowledge, 
interest, power and position must also be taken into 
account in stakeholder analyses.
 ► Both top- down and bottom- up approaches in policy 
implementation must be considered when analysing 
policy actors at the global, national and local levels.
What do the new findings imply?
 ► The developed framework addresses a gap in health 
policy research by offering a practical tool for an-
alysing the characteristics of policy actors and by 
tackling the intricacies of assessing complex con-
cepts while conducting stakeholder analyses.
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retrospectively to assess stakeholder roles in policy 
processes, or prospectively to inform future policy direc-
tions.2 It covers the entire policy cycle, from agenda 
setting to policy formulation, adoption, implementation 
and evaluation.3 Stakeholders with competing ideologies 
or interests can influence formulation of policies4 and 
can reshape adopted policies by contesting and negoti-
ating their implementation.5
Stakeholders are typically analysed by their interests, 
position and, especially, their power.6 Interest refers to 
their concerns about how a particular policy will affect 
them7; position reflects their level of support for or oppo-
sition to the policy1; and power is their ability to affect 
policy, reflecting their resources and ability to mobilise 
them.1 While interest and position can be straightfor-
ward to ascertain, assessing power is more complex as 
it impacts on all steps of the policy process.8 Yet, power 
is often poorly characterised in empirical research on 
implementation of disease management policies, espe-
cially in low- and- middle income countries (LMICs).9 10
Sriram et al describe power as conceptually fluid, 
viewed on different levels, political angles and sociocul-
tural lenses.8 In health policy, Lukes’ three faces of power 
include a first, visibly played out in the formal political 
arena; a second involving formal and informal processes 
underpinning development of political agendas; and a 
third, invisible but shaping the narrative on measures 
considered acceptable.11 Gaventa expands this approach, 
introducing the concept of a ‘power cube’ with one 
dimension represented as visible, hidden and invisible, 
as in Luke’s model; and a second categorising power 
as local, national and global. A third divides spaces for 
engagement into closed or decision- making by an elite 
group of actors; invited spaces that allow participation by 
citizens or beneficiaries; and claimed or created spaces 
emerging from social mobilisation or natural gatherings 
outside formal policy arenas. Gaventa argues that signif-
icant changes are possible by aligning strategies to axes, 
like a Rubik’s cube.12 VeneKlasen and Miller distinguish 
four expressions of power. ‘Power over’ is the capability 
of those who hold power to exert influence on those 
without, ‘power with’ involves synergy with different 
actors, ‘power to’ pertains to one’s own ability to act, 
while ‘power within’ refers to self- awareness and recogni-
tion of self- worth leading to action.13
In policy implementation, power relates to the distri-
bution of authority in a system. The traditional top- down 
model sees actors deriving power from their place in a 
de facto hierarchy. Policies are formulated at national or 
international levels and cascaded downwards,14 those 
in higher tiers setting objectives to be accomplished by 
implementers.10 Bottom- up implementation focuses 
on the active role of implementers and their ability to 
modify or react to policies based on local context.14 It 
views implementation as interactive, involving negotia-
tion and conflict.14
Stakeholder analyses face several challenges. Fast- 
changing policy environments can shift stakeholder 
positions so findings are time- bound.15 Having many 
potential stakeholders may pose difficulties, as does the 
ability to delineate personal and role- driven opinions of 
those in organisations. Other challenges include sensi-
tivities around asking about power and interest, and 
potential bias arising from the position of the analysts, 
often immersed in the policy process themselves.6 These 
can be addressed using longitudinal studies that capture 
changing positions, limiting analyses to main stake-
holders, capturing personal views and organisational 
positions, triangulating primary data against secondary 
sources, and self- awareness and diversity of analysts in 
research.6
Another challenge is that many existing analyses fail 
to fully describe the process by which power, position 
and interest are operationalised. Given the complexity 
involved, understanding how researchers assessed stake-
holder characteristics becomes crucial to guide later 
stakeholder engagement and interventions. The process 
starts with defining concepts, choosing variables or 
domains to represent these concepts and operational-
ising them using relevant indicators. Where several ques-
tions measure a single concept, scales or indices can be 
composite measures.16
This paper contributes to the methodology of stake-
holder analysis, especially the operationalisation of 
stakeholder characteristics in health policy implemen-
tation research. We reviewed conceptual approaches in 
stakeholder analyses, proposed an analytical framework 
that drew on those conceptual approaches and included 
domains and value scales used to operationalise stake-
holder characteristics. The framework was reviewed by 
experts and field- tested by diverse policy actors involved 
in a study of hypertension in the Philippines.17 The field- 
testing of the framework with implementation of the Phil-
ippine Package of Essential Non- communicable Disease 
(NCD) Interventions, to identify and manage NCD risk 
factors in primary care,18 provides a rich backdrop for 
framework development, involving interaction with 
diverse policy actors within a pluralistic health system.
METHODS
Scoping review
We performed several interlinked steps (figure 1). First, 
a scoping review of stakeholder analyses mapped key 
concepts and identified how stakeholder characteristics 
were operationalised, defined and measured in health 
research literature.
Our scoping review process was guided by Arksey and 
O’Malley’s framework, with five stages: identifying the 
research question, identifying relevant studies, study 
selection, data charting and collating, and reporting 
results.19 We followed the Preferred Reporting Items 
of Systematic Reviews and Meta- Analysis extension 
for Scoping Reviews (PRISMA- ScR) (figure 2 and 
online supplemental appendix 1).20 Papers between 
January 2009 and July 2019 that included definitions of 
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stakeholder characteristics in the analysis were eligible. 
Studies that did not provide definitions of characteristics 
were excluded.
Characteristics of power and influence were central 
to the analytical process. PubMed was searched with the 
key words ‘Stakeholder analysis AND power’ and ‘Stake-
holder analysis AND influence’ which together gener-
ated 433 records. Duplicates were filtered using EndNote 
V.X9, leaving 411 unique records. A researcher screened 
titles and abstracts for eligibility. Sixteen were deemed 
relevant and analysed (online supplemental appendix 2). 
A manual search of selected references gathered relevant 
guidelines on methodologies for operationalising stake-
holder characteristics, and were reviewed as part of the 
framework development.
Our data charting form extracted the following from 
each paper: year of publication, authors, study location, 
purpose of analysis, framework and guidelines used, 
definitions of stakeholder characteristics, and domains 
used to assess characteristics. Using a narrative synthesis 
approach, the scoping review generated an initial frame-
work synthesising definitions and domains of stakeholder 
characteristics such as knowledge, interest, position and 
power, and methods used to assess them.
Review by experts
The initial framework was sent for peer- review by interna-
tional experts on health policy and health systems lead-
ership, purposively selected due to (1) their expertise in 
conducting policy and stakeholder analyses in LMICs, 
(2) self- identifying as policy analysts and applying their 
skills in different projects, and (3) work highly regarded 
by peers or frequently cited. We initially contacted five via 
email, with three providing detailed reviews. They were 
from academia with doctoral degrees in health policy 
and politics and at least 10 years of experience in health 
policy and systems research. Specifically, the experts 
were asked to comment on the definitions, domains and 
scales used to assess stakeholder characteristics related 
to knowledge, power, interest and position. This was 
Figure 1 Methodology for framework development.
Figure 2 Flow diagram of scoping review on stakeholder characteristics.
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followed by a review of literature provided by experts, 
who guided us to particular theories and empirical work 
on power,11 12 21 22 which we supplemented with a manual 
search of selected references. We included references 
based on their fit with our study and revised our frame-
work based on expert comments and the literature.5 8 23
Field-testing of the framework in the Philippine context
We field- tested the revised framework in a study on 
implementation of an NCD policy in the Philippines to 
ascertain its appropriateness for assessing the levels of 
knowledge, interest, position and power of stakeholders. 
Field- testing was via key informant interviews from August 
2019 to March 2020, and a 1- day consensus workshop in 
November 2019.
Eighteen key informants were selected via purposive 
sampling, which were identified either through docu-
ment review or a snowball technique wherein respon-
dents were requested to identify stakeholders with whom 
they usually collaborate. Identified stakeholders were 
eligible for interview based on their engagement with 
policy implementation and views of other stakeholders. 
This technique was particularly useful in narrowing down 
interviewees as it identified those currently wielding 
power in implementation processes, and those that can 
potentially influence other implementers.
A semistructured interview topic guide was developed 
based on the framework (online supplemental appendix 
3). The interviews took between 30 and 90 min and were 
conducted in a mix of Tagalog and English depending on 
the preference of the interviewee. Written consent forms 
were requested, and participant numbers were assigned 
to interviewees to protect their identities.
A 1- day consensus- building workshop was conducted 
to further field- test the framework by assessing key stake-
holders according to their level of knowledge, interest, 
power and position, and to evaluate the framework’s 
performance. Nine stakeholders from academic institu-
tions, non- government organisations, professional soci-
eties, local governments and frontline health workers 
participated in the consensus workshop and engaged in 
discussions (table 1).
Given the varied experiences and perspectives, and the 
potential professional hierarchies in the assembled group, 
the workshop was designed to solicit expert views using 
elements of focus group discussion to allow participants 
and facilitators to freely share knowledge and evidence 
and discuss each topic; and elements of the Delphi 
process, allowing participants to provide anonymous 
input.24–27 The workshop sought to achieve consensus on 
four topics: (1) identification of key stakeholder groups; 
(2) understanding of definitions of framework concepts, 
domains, indicators and scoring; (3) scoring based on 
stakeholder characteristics as defined in the analytical 
framework; and (4) determining strategies on engaging 
organisations identified as important and influential in 
implementation.
From an initial long list of stakeholders, participants 
narrowed the list down to 14 key actors. Following a 
framework orientation presentation, participants then 
scored the key actors on a scale of 0–3 based on their 
level of knowledge, interest and power; while stakeholder 
position was scored 1–5 based on the strength of support 
for the policy. After a first round of scoring, a summary 
was shown to the participants and a facilitated discus-
sion ensued which clarified participants’ understanding 
and achieved consensus on the definitions of framework 
concepts, domains, indicators and scores, and to gather 
information on their experiences of assessing levels of 
stakeholder characteristics in a Delphi exercise. This was 
followed by further focus group discussion to achieve 
consensus on the scoring of each key stakeholder’s level 
of knowledge, interest, power and position. Our general 
consensus processes used a conventional group problem- 
solving approach involving (1) problem clarification, (2) 
agreement on deliberation procedures, (3) information 
and perspective sharing, (4) option development, (5) 
group selection of the preferred option,26 which was 
operationalised using simple majority vote. Key points 
from the discussion were recorded by the research team 
and integrated into the final version of the framework. 
A power- position matrix was then shown to the partici-
pants based on the results and a consensus- oriented 
focus group discussion ensued to determine strategies 
for engaging with stakeholders based on their location 
in the matrix.
Key informant interviews and the consensus building 
workshop were recorded, with audio files transferred to 
an encrypted laptop and transcribed verbatim. Feedback 
from the interviews and consensus building exercise were 
then taken into account in the revision of the framework 
to ensure its appropriateness in analysing stakeholders in 
the Philippine context and the topic area (CVD). The 
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framework was reviewed and revised at every step by the 
researchers who were health professionals and/or faculty 
members from well- known universities.
RESULTS
Scoping review
Sixteen articles were analysed, of which 12 applied to 
policy processes, 2 to health interventions, 1 was set in an 
organisation and 1 was a methodological paper. There 
was a mix of 9 prospective analyses and 7 retrospective 
analyses included in the review. In the 15 empirical 
studies included, analyses were applied across different 
contexts with 3 studies conducted in low- income econo-
mies, 4 in lower- middle income economies, 4 in upper- 
middle income economies and 4 in high- income econ-
omies.
The review revealed the absence of a standard way of 
operationalising characteristics in a stakeholder anal-
ysis, with different empirical studies over the past decade 
applying a variety of frameworks and guidelines. Some 
studies followed a single guideline when analysing stake-
holder characteristics. Table 2 presents an overview of 
the different frameworks, including the stakeholder 
characteristics assessed in each study. Among those 
that followed a single framework, most used Schmeer’s 
guidelines, an approach recommended by WHO,1 which 
proposed to analyse stakeholders based on seven char-
acteristics. Studies that adapted this, however, selected 
anywhere from 2 to 7 of the proposed characteristics, 
depending on which were deemed appropriate to the 
context being analysed.28–31 Six of the 16 papers did not 
follow a particular guideline, but drew on several sources 
to define and operationalise stakeholder characteristics. 
An example of this is Abiiro and McIntyre’s study on the 
premium payment policy in Ghana which adapted defi-
nitions of characteristics from various methodological 
papers and studies, and determined domains of power 
from stakeholder insights.32
When defining stakeholder characteristics, power and 
influence were used interchangeably in several studies 
and were defined, variously, as the ability of a stakeholder 
to affect policy formulation or implementation, their 
access to resources and ability to mobilise them.6 33–35 
Three studies defined power as the stakeholder’s ability 
to influence policy, or assessed power and influence sepa-
rately.29 32 36
Interest was defined in terms of the advantages or 
disadvantages that policy implementation conferred on a 
stakeholder, or their political stake or degree of involve-
ment in an issue.1 37 The definition of position was more 
or less consistent across different studies, and indicates 
the level of support or opposition towards a policy or a 
programme.
There seems to be a general agreement across studies 
on the definitions of power, interest and position, 
suggesting that there is an agreement at the conceptual 
level. There is, however, considerable variability in how 
these characteristics were operationalised in guidelines 
and empirical work.
Table 3 shows domains that have been proposed in 
guidelines and methodological papers to assess stake-
holder characteristics as well as domains that have been 
applied in empirical studies. We examined five guidelines 
and frameworks cited in the studies shown in table 2, and 
one methodological paper identified in our search. Out 
of these six, we included four that provided domains for 
assessing power, interest or position in the table.
For studies that conducted analyses in specific policy 
contexts, only 7 out of 15 papers provided details on what 
specific aspects of stakeholder characteristics were evalu-
ated. Among the seven papers that included such details, 
six conducted prospective analyses with stakeholders 
at the agenda setting,36 38 policy formulation32 33 39 and 
intervention planning stages.35 One paper conducted a 
retrospective analysis applied to policy implementation.28
It should be noted that while the guidelines offered 
well- defined characteristics, some offered flexibility 
for researchers to use their own assessment criteria 
depending on their aim or specific contexts. Even in 
studies that proposed domains, some of these were 
defined broadly, such as ownership or access to resources, 
which still allows for researchers to ultimately define 
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Table 3 Domains used in stakeholder analysis guidelines, methodological papers and studies to assess power and influence, 
interest, and position
Domains for characteristics
No of guidelines/method 
papers (N=4)
No of empirical studies 
(N=7)
Domains for power or influence
Technical/professional knowledge/skills 147 328 32 36
Decision- making 328 33 38
Political/influential position 21 47 2 28 36
Financial power/money 31 43 47 2 28 36
Legal mandate 147 228 32
Human 11
Technological 11
Ability to place the issue on the agenda 233 38
Legislative power for policy approval 232 38
Influence over policy outcomes 232 38
Attribution of power (actor’s power as perceived by themselves and others) 149
Ability to mobilise on the issue 11 235 38
Coercive: physical resources of force, violence or restraint 243 47
Normative: symbolic influences 143
Connections to influential stakeholders 147
Ownership/control of resources 149 232 35
Voting power/influence over voters 132
Involvement in policy formulation 132
Willingness to engage in policy discussions 139
Ability to be heard in discussions 139
Ability to influence other actors 139
Ability to influence public opinion 132
Directly or indirectly take action for or against the policy 135
Control over implementation at the local level 132
Determine policy success and sustainability 132
Possession of privileges 135
Ability to organise members 132
No of votes 147
Domains for interest
Overall perceived impact 11 132
Key interest/concerns 11 132
Professional affiliation 133
Stakeholder agendas 133
Status within the community 133
Pursue benefits for stakeholder 147
Achieve equitable treatment for player’s group 147
Advance player’s view of common good 147
Garner more resources 147
Preserve power 147
Domains for position
Level of support or opposition 21 47 628 32 33 35 38 39
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which particular resources to assess. Examination of 
empirical studies, therefore, provides helpful insights on 
which domains can be applied to actual policy contexts. 
Table 3 reflects common domains used for power or 
influence, interest and position revealed by our review.
Based on the scoping review findings, four character-
istics were selected for inclusion in our adapted frame-
work: knowledge, interest, power and position. Power, 
interest and position were the most frequently assessed 
characteristics in the stakeholder analysis literature, 
while knowledge was included in recognition that a stake-
holder’s understanding of a policy may determine their 
level of interest and perception of how it can potentially 
affect them.32
Aside from the results of the scoping review, a meth-
odological paper and several studies informed the devel-
opment of the initial analytical framework; these include 
Schmeer’s definitions of characteristics, value scales from 
Caniato et al, and domains to assess power from Abiiro 
and McIntyre’s study.1 30 32 Table 4 shows a summarised 
version of the initial stakeholder analysis framework 
developed for policy implementation research and the 
subsequent modifications made after the expert review, 
key informant interviews and the consensus building 
exercise.
Feedback from expert review
The health policy experts provided feedback on the defi-
nitions of stakeholder characteristics and the domains 
used to assess them in the initial version of the framework. 
For knowledge, one expert suggested that the domains 
and value scales included seemed to imply that the policy 
is clearly laid out when, in reality, policies can be vague or 
not publicised. To address this comment, source of infor-
mation was added as a domain in the framework to iden-
tify gatekeepers and determine the process and potential 
gaps in the transfer of knowledge.
With regard to interest, an expert argued that the 
concept refers to the concerns and driving motivations 
of stakeholders and how policies impact their organisa-
tion. Based on this feedback, the definition of interest 
was revised and domains were changed to reflect whether 
the policy is considered as a priority or perceived to affect 
the stakeholder in any way.
All three experts provided comments on the charac-
teristic of power and suggested a review of relevant theo-
ries and empirical work analysing power to see how these 
can be incorporated in the framework. Following this 
feedback, additional literature on power was reviewed to 
determine its different dimensions and how these can be 
assessed in practice. A study by Dalglish et al applied to 
the policy for integrated community case management 
of childhood illness in Niger was particularly relevant 
as it examined a range of power theories and opted to 
select three dimensions of power deemed to be rele-
vant to the country’s context: political authority, finan-
cial resources and technical expertise.23 These three 
domains also emerged in the scoping review and were 
thus incorporated in the revised analytical framework to 
be field- tested in the Philippine setting.
Still pertaining to power, one of the experts commented 
on how the domains seemed to be underpinned by a 
top- down view of implementation and may not take into 
account bottom- up approaches. Accordingly, the domain 
of ‘Leadership’ was added to describe a stakeholder’s 
ability to convene partners and mobilise them to work 
together to implement a policy. The additional domain 
was drawn from Lehmann and Gilson’s study on the 
micro- practices of power of community health workers 
in South Africa.5
Finally, one expert highlighted how position and 
interest are linked, as a stakeholder’s perception of how 
policy will impact their organisation can affect their level 
of support. As a result, another domain, ‘actions taken 
to demonstrate support or opposition’, was added to 
the framework to draw out ways in which stakeholders 
express their positions during policy implementation.
Field-testing the appropriateness of the framework to CVD 
policy in the Philippines
Overall, the framework was found to be acceptable and 
appropriate to the policy context in the Philippines 
during the interviews and consensus building exercise. 
There were clarifications and discussions, however, about 
some of the characteristics and on how to evaluate levels 
of knowledge, interest, power and position of stake-
holders, which led to further refinement of the frame-
work.
With regard to knowledge, participants in the group 
consensus exercise differentiated between operational 
knowledge of the policy and understanding the overall 
policy goal, as some stakeholders may know how to imple-
ment the policy’s components, without necessarily being 
aware of what the policy seeks ultimately to achieve. 
Following discussions, four domains were included in 
the final framework to reflect awareness of policy, oper-
ational knowledge of policy, understanding of policy 
rationale and source of information. Value scales were 
likewise revised to categorise extensive knowledge as 
understanding both policy rationale and implementa-
tion issues, general knowledge as operational know- how 
in implementation, while limited knowledge refers to 
awareness about the policy without knowing specific 
details about it.
Another point of discussion during the group exercise 
was the link between awareness and interest, and how 
knowledge of the policy can determine level of interest. 
Those unaware of the policy may thus appear to have 
low interest, highlighting the need to assess interest in 
conjunction with knowledge. Interview findings suggest 
that asking about interest can also be potentially sensitive 
as it delves into the underlying motivations of different 
stakeholders. The direct question about policy impact on 
the organisation seemed to be unclear for some stake-
holders and follow- up questions exploring opportunities 
and costs of the policy, as well as providing examples, 
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helped stakeholders think more concretely about it. In 
the framework, this translates into specifying perceived 
impact as opportunities and costs to the stakeholder.
An important issue tackled during the consensus work-
shop was whether to rate stakeholders based on their 
potential power or actual exercise of power. A stake-
holder, for example, may have resources and, as such, the 
potential to be involved in implementation, but for one 
reason or another does not fully exercise their potential 
power. To resolve the issue, the participants reached an 
agreement to rate the power characteristic as potential 
power, and to reflect the actual exercise of power when 
rating overall position.
A final issue on the link between personal attributes and 
stakeholder power arose during the interview process. 
Within organisations there may be charismatic and 
Table 4 Summary of stakeholder characteristics, definitions, domains and value scales in the initial framework, and key 
changes made after expert review, key informant interviews and consensus building exercise
Initial framework based on scoping review Key changes after expert review
Key changes after key informant interviews and 
consensus building exercise
Knowledge
Definition: Stakeholder’s level of knowledge and 
understanding of the policy
Domains:
 ► Knowledge of policy (awareness and ability to 
describe key features)
 ► Understanding of policy purpose
Value scales: 1—No or minimum knowledge, 2—
General knowledge, 3—Extensive knowledge
Definition: Retained
Changes in domains:
 ► Knowledge of policy and its implementation




 ► Operational knowledge of policy
 ► Awareness of policy (added)
Changes in value scales: 0—No knowledge, 1—
Limited knowledge, 2—General knowledge, 3—
Extensive knowledge
Note: General knowledge defined as operational 
knowledge on policy, while extensive knowledge 
includes both operational knowledge and 
understanding of policy rationale
Interest
Definition: Extent to which stakeholders perceive 
policy implementation as relevant and likely to affect 
them
Domains:
 ► Relevance of policy to stakeholder
 ► Willingness to participate in implementation
 ► Likelihood to affect stakeholder
Value scales: 1—No or minimum interest, 2—Limited 
interest, 3—General interest, 4—High interest
Changes in definition: Stakeholder’s motivations 
and perceived impact of policy implementation to 
their own organisation
Changes in domains:
 ► Policy objective core to organisation’s mission
 ► Policy is a priority for organisation





 ► Perceived policy impact in terms of opportunities 
and costs to the stakeholder
Changes in value scales: 0—No Interest, 1—
Limited interest, 2—General interest, 3—High 
interest
Power
Definition: The ability of the stakeholder to affect 
policy implementation
Domains:
 ► Capacity to design policies
 ► Capacity to fund policy implementation
 ► Capacity to implement policy
 ► Ability to lead and gather support from 
stakeholders
 ► Ability to influence public opinion
Value scales: 1—Low, 2—Medium, 3—High




 ► Political authority
(a) Direct: Derived from hierarchy, legal mandate, 
regulatory regimes.
(b) Indirect: Ability to create incentives and 
constraints for other act.
 ► Financial capacity
Possession and control of financial resources
 ► Technical expertise
Technical capacity to produce,interpret and 
disseminate knowledge and information.
 ► Leadership
Ability to build partnerships and motivate other 
stakeholders for or against policy implementation.
Changes in value scales: 1—Low, 2—Medium, 
3—High
Note: Stakeholders rated based on possession and 
control of resources and ability to make decisions in 
policy implementation
Changes in definition: The potential ability of the 




(a)Ability to build partnerships, motivate other 
stakeholders and/or shape opinion for or against 
policy implementation.
(b)Personal attributes of individuals within the 
organisation which can include charismatic 
authority, personal commitment and motivation
Changes in value scales: 1—Low, 2—Medium, 
3—High
Note: Stakeholders rated based on possession and 
control of resources and potential to affect policy 
implementation
Position
Definition: Whether the stakeholder supports, 
opposes or is neutral about policy implementation
Domains
 ► Degree of support or opposition to policy
Value scales:




 ► Actions taken to demonstrate support or 




 ► Degree of support or opposition to policy 
expressed through use of potential power or 
resources
 ► Actions taken to demonstrate support or 
opposition to policy
Changes in value scales: 1—Strong opponent, 
2—Moderate opponent, 3—Neutral, 4—Moderate 
support, 5—Strong support
Source: Definitions, domains and value scales for the frameworks were adapted from elements in the methodological papers and studies of Varvasovsky and 
Brugha (2000), Schmeer (2000), Abiiro and McIntyre (2013), Lehmann and Gilson (2013), Caniato et al (2014), Dalglish et al (2015) and Sriram et al (2018) and 
feedback from health policy experts and stakeholders.
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motivated individuals that help move policy implemen-
tation forward. Thus, personal attributes were included 
in the final framework under the domain of leadership 
to reflect the role of individuals in policy implementa-
tion. Table 5 shows the final revised framework based on 
combined feedback from expert consultations, interviews 
and group consensus exercise.
DISCUSSION
In this study, we present an adapted framework for stake-
holder analysis that draws on empirical research, theory 
and advice from health policy experts, specifically devel-
oped for application to health policy contexts in LMICs. 
Its key domains and characteristics are fully operational-
ised. From our experience of taking a flexible and iter-
ative approach to develop and field- test the framework 
in the Philippines, we believe it is a practical tool that is 
able to assess the stakeholder landscape in which a health 
policy is implemented and examine complex stakeholder 
characteristics in a rigorous, transparent, yet straightfor-
ward manner—a process that is seldom described well in 
empirical stakeholder analyses.6
While existing guidelines and frameworks for stake-
holder analyses clearly define stakeholder characteris-
tics, the process of operationalising or measuring these 
concepts is often left to the discretion of researchers to 
ensure they are fit for purpose and are adapted to their 
particular context. It is, however, important that empir-
ical studies explicitly state the criteria for assessing char-
acteristics to minimise bias,2 reduce ambiguity and allow 
the analysis to be replicated by other scholars intending 
to do similar studies. Our study contributes to the stake-
holder analysis literature by describing our process, and 
the intricacies of identifying domains to include and 
putting a value on abstract concepts. This is a critical step 
required in analyses, but posing challenges that are not 
discussed adequately in the literature. By synthesising 
the most frequently used domains in studies, bringing 
insights from studies on power of actors outside of stake-
holder analyses and going through an iterative process of 
operationalisation, the study offers a framework that can 
more easily be adapted and applied by other researchers. 
The framework also contributes to the overall discussion 
on power of actors and how to assess this, especially at the 
policy implementation stage.
The development process identified multiple intersec-
tions between stakeholder characteristics. Level of knowl-
edge was linked to level of interest, as stakeholders unaware 
of the policy may be perceived as having low interest in its 
implementation, suggesting the need to analyse interest 
in conjunction with knowledge. This finding is consis-
tent with Abiiro and McIntyre’s study, which postulated 
that a stakeholder’s understanding of a policy affects 
its perceived impact or interest in it.32 Interest was also 
linked to position, as the perceived impact of the policy 
on the stakeholder determines whether or not they will 
support or oppose its implementation. This finding is 
Table 5 Finalised framework for stakeholder analysis 
applied to the PhilPEN policy implementation context
Knowledge
Definition: Stakeholders’ 
knowledge and understanding of 
the policy
Domains:
 ► Awareness of policy
 ► Operational knowledge of 
policy
 ► Understanding of policy 
rationale
 ► Source of information
Value scales:
0—No knowledge
Stakeholder is not aware of policy
1—Limited knowledge
Stakeholder is aware of policy but 
have minimal knowledge about its 
purpose or implementation
2—General knowledge
Stakeholder has operational 
knowledge about policy
3—Extensive knowledge
Stakeholder understands policy 




motivations and perceived impact 
of policy implementation to their 
own organisation.
Domains:
 ► CVD control core to 
organisation’s mission
 ► Policy is a priority for 
organisation
 ► Perceived policy impact in 
terms of opportunities and 
costs to the stakeholder
Value scales:
0—No interest
Policy is not considered a priority 
and not perceived to impact 
stakeholder
1—Limited interest
Policy is not considered a priority 
and has minimum impact on 
stakeholder
2—General interest
Policy is a priority and has 
moderate impact on stakeholder
3—High interest
Policy is part of the stakeholder’s 
core mission and has high 
perceived impact on stakeholder
Power
Definition: The potential ability 
of the stakeholder to affect policy 
implementation
Domains:
 ► Political authority
a. Direct: Derived from 
hierarchy, legal mandate, 
regulatory regimes.
b. Indirect: Ability to create 
incentives and constraints 
for other actors.
 ► Financial capacity
Possession and control of financial 
resources
 ► Technical expertise
Technical capacity to produce, 
intrepet and disseminate 
knowledge and information
 ► Leadership
a. Ability to build partnerships, 
motivate other stakeholders 
and/or shape opinion 
for or against policy 
implementation.
b. Personal attributes of 
individuals within the 








Stakeholder possesses and has 
control over use of one to two 
sources of power, low potential to 
affect policy implementation
2—Medium power
Stakeholder possesses and 
has control over use of two to 
three sources of power, has 
moderate potential to affect policy 
implementation
3—High power
Stakeholder possesses and 
has control over use of three 
to four sources of power, has 
high potential to affect policy 
implementation
Continued
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consistent with the definition of interest in other studies 
as ‘positive and negative impact’40 or ‘advantages and 
disadvantages’ of the policy to the stakeholders.1
The link between power and position was also explored, 
as the question of whether to measure potential power 
based on resources versus actual exercise of power deter-
mined through stakeholder actions became pertinent. 
Discussions revealed that there is value in looking at 
these two separately in order to identify stakeholders with 
high potential power, but who are not fully exercising 
this power in their implementation efforts. Such differ-
entiation is also helpful when determining appropriate 
stakeholder engagement strategies. As a result, power, 
as used in the framework, meant potential power, while 
position reflected the exercise of power in terms of the 
actual use of available resources and actions taken by the 
stakeholder to support or oppose policy implementation.
The operationalisation process highlighted the diffi-
culty of assessing stakeholder power. With the abundance 
of theories on power and its implicit and explicit mani-
festations in stakeholder interactions,8 it was challenging 
to determine which particular domains to include in the 
framework. Domains of power found in the stakeholder 
analysis literature typically identify access to sources of 
power, but discussions with stakeholders revealed that 
access to these sources is only one aspect of power, 
and effective use of potential power to achieve policy 
outcomes is also key but more challenging to assess. Eval-
uating the exercise of power by different actors in a stake-
holder analysis involves the examination of policy actors 
interacting at the global, national and local levels. At the 
international level, some studies have shown that donors 
can control implementation outcomes through condi-
tions stipulated in funding agreements41 and can also 
influence different stages of the policy process through 
leverage of financial resources, technical expertise and 
intersectoral pressure.21 Frontline providers, on the other 
hand, can exercise ‘micro- practices of power’ through 
day- to- day decision- making that can either support or 
subvert intended policy outcomes.5 Therefore, a compre-
hensive assessment of power requires sampling that 
provides sufficient representation of perspectives from 
global down to local levels. This task becomes even more 
complex and onerous in highly heterogeneous settings, 
which may result from factors, such as health system 
decentralisation, as in the Philippines.
Furthermore, when analysing stakeholders involved in 
policy implementation, it is important to consider incor-
porating both top- down and bottom- up approaches to 
account for the important role that frontline workers 
play in the implementation process. Implementing 
actors, often considered as having low power, can actually 
exercise very high levels of discretionary power (eg, by 
withholding labour), which, when done as a group, can 
undermine a policy’s goals.5
The new framework has several limitations. Since it was 
applied in the context of health policy implementation 
in an LMIC context, discussions were mostly focused on 
assessing characteristics of actors in implementing the 
policy as opposed to their ability to advocate or design 
policies, which would be more relevant at the policy 
formulation stage. While the domains can also be seen as 
relevant for assessing actors across different policy stages, 
high- income economy settings or different fields outside 
health policy research, its application to these contexts is 
beyond the scope of the study.
Although the study touched on the concept of power, 
it focused more on practical domains for assessing power 
among stakeholders, which was mainly sourced from 
previous empirical studies and feedback from experts 
and stakeholders. Domains of power identified in the 
framework were drawn mostly from more visible sources 
of power, or those that can be verified through document 
review, interviews and consensus among stakeholders. 
While the results of the interviews can provide some 
insights on the less visible forms of power at play during 
implementation, an additional layer of analysis may be 
needed to situate power dynamics between actors within 
the broader macro- political context and societal struc-
tures, such as those along the lines of gender, class or 
race.10 An example of this process of contextualisation 
can be seen in Gilson et al’s study in South Africa and 
Tanzania which identified situational, structural, exoge-
nous and cultural factors affecting stakeholder interac-
tions in universal health coverage debates.6 Sources of 
power should also be treated as context dependent and 
time bound as the power of stakeholders may shift over 
time and may only be applicable in certain contexts.10
Another limitation is that the scoping review only used 
one database, PubMed. While we reviewed additional 
Position
Definition: Whether the 
stakeholder supports, opposes 
or is neutral about policy 
implementation
Domains:
 ► Degree of support or opposition 
to policy expressed through 
use of potential power (sources 
of power)
 ► Actions taken to demonstrate 
support or opposition to policy
Value scales:
1—Strong opponent
Stakeholder uses potential power 
to strongly act against policy 
implementation
2—Moderate opponent
Stakeholder uses potential power 
to moderately act against policy 
implementation
3—Neutral
Stakeholder does not use potential 
power and does not act for or 
against policy implementation
4—Moderate support
Stakeholder uses potential power 
to moderately act in support of 
policy implementation
5—Strong support
Stakeholder uses potential power 
to act strongly in support of policy 
implementation
Source: Definitions, domains and value scales for the framework were 
adapted from elements in the methodological papers and studies of 
Varvasovsky and Brugha (2000), Schmeer (2000), Abiiro and McIntyre 
(2013), Lehmann and Gilson (2013), Caniato et al (2014), Dalglish et al 
(2015) and Sriram et al (2018) and feedback from health policy experts 
and stakeholders.
Table 5 Continued
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literature provided to us by the experts we consulted, 
allowing us to draw insights from other relevant fields 
such as political science, it was beyond the scope of the 
project to attempt a comprehensive review of literature 
from all the fields that might have something to say. We 
felt given the aim of the study, this approach enabled 
us to include seminal papers on stakeholder analysis. 
Also, the stakeholders who took part in the consensus 
building exercise were mostly frontline implementers, 
and higher- level actors were unable to participate despite 
repeated efforts to reach them. However, as noted above, 
the involvement of frontline implementers ultimately 
strengthened the framework refinement by representing 
crucial bottom- up perspectives during the development 
process, while insights from higher- level policy makers 
were captured during key informant interviews from 
international and national stakeholders.
CONCLUSION
While there is a wealth of theories, guidelines and 
approaches, empirical works providing details on how 
stakeholder characteristics are assessed remain scarce. 
We offer an adapted framework for stakeholder analysis 
that builds on key advances in the field and has been 
shown to be applicable to health policy implementation 
research in an LMIC context. The paper presents prac-
tical guidance on how to develop the framework domains 
and its specific characteristics, emphasising the impor-
tance of revisiting how complex concepts such as knowl-
edge, interest, power and position have been defined and 
operationalised in stakeholder analysis studies.
While the framework was developed in the context 
of the Philippine health system, it is likely to be highly 
relevant to researchers conducting stakeholder analyses 
in other LMIC contexts. This is especially important 
for comparisons of stakeholders across countries, 
which require consistency in the definition of concepts, 
domains, indicators and scoring. Our experience empha-
sises the need for researchers conducting stakeholder 
analyses to include details and accounts of how they have 
operationalised and assessed the concepts, as they seek to 
arrive at an overall understanding of the diverse ways in 
which actors relate and interact with each other to shape 
and influence policy processes.
Acknowledgements The authors would like to thank the Wellcome Trust/
Newton Fund- MRC Humanities & Social Science Collaborative Award scheme 
(200346/Z/15/Z) for providing funding for this research. MAB would like to thank 
Chevening Scholarships, the UK government’s global scholarship programme, 
funded by the Foreign and Commonwealth Office (FCO) and partner organisations 
for her scholarship to study in the UK, and the London School of Hygiene & Tropical 
Medicine Trust Fund for the travel grant support to conduct the study.
Contributors DB, BP, MM, LMP- V and Christine Candari conceptualised the work 
described. MAB, DB, BP and LMP- V contributed to the development of the study 
design and data collection. MAB produced the first draft of the manuscript which 
was critically revised by DB, BP, LMP- V and MM. All authors revised and approved 
the final version.
Funding This study was funded by Wellcome Trust/Newton Fund- MRC Humanities 
& Social Science Collaborative Award scheme 200346/Z/15/Z.
Competing interests All authors report grants from Wellcome Trust, during the 
conduct of the study; LPV reports grants from Philippine College of Physicians, 
non- financial support from Sanofi and Cadila and grants from WHO Asia Pacific 
Observatory, outside the submitted work.
Patient and public involvement Patients and/or the public were not involved in 
the design, or conduct, or reporting, or dissemination plans of this research.
Patient consent for publication Not required.
Ethics approval Ethical approval was obtained from the ethics research boards of 
the University of the Philippines Manila- Panel 2 and London School of Hygiene and 
Tropical Medicine.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the 
article or uploaded as supplementary information.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
ORCID iDs
Marysol Astrea Balane http:// orcid. org/ 0000- 0002- 7466- 5764
Benjamin Palafox http:// orcid. org/ 0000- 0003- 3775- 4415
Martin McKee http:// orcid. org/ 0000- 0002- 0121- 9683
REFERENCES
 1 Schmeer K. Stakeholder analysis guidelines, 2000. Available: https://
www. who. int/ workforcealliance/ knowledge/ toolkit/ 33. pdf [Accessed 
3 Mar 2019].
 2 Varvasovszky Z, Brugha R. How to do (or not do). A stakeholder 
analysis. . Oxford Univ Press, 2000: 15. 338–45. http:// dess. fmp. ueh. 
edu. ht/ pdf/ Zsuzsa_ Varvasovsky_ 2000_ stakeholder_ analysis. pdf
 3 Howlett M, Ramesh M. Studying public policy: policy cycles and 
policy subsystems. second ed. Toronto: Oxford University Press, 
2003.
 4 Surjadjaja C, Mayhew SH. Can policy analysis theories predict and 
inform policy change? reflections on the battle for legal abortion in 
Indonesia. Health Policy Plan 2011;26:373–84.
 5 Lehmann U, Gilson L. Actor interfaces and practices of power in 
a community health worker programme: a South African study of 
unintended policy outcomes. Health Policy Plan 2013;28:358–66.
 6 Gilson L, Erasmus E, Borghi J, et al. Using stakeholder analysis to 
support moves towards universal coverage: lessons from the shield 
project. Health Policy Plan 2012;27 Suppl 1:i64–76.
 7 Roberts M, Hsiao W, Berman P, et al. Getting health reform right. 
Oxford: Oxford University Press, 2008.
 8 Sriram V, Topp SM, Schaaf M, et al. 10 best resources on power 
in health policy and systems in low- and middle- income countries. 
Health Policy Plan 2018;33:611–21.
 9 Gilson L, Raphaely N. The terrain of health policy analysis in low and 
middle income countries: a review of published literature 1994-2007. 
Health Policy Plan 2008;23:294–307.
 10 Erasmus E, Gilson L. How to start thinking about investigating power 
in the organizational settings of policy implementation. Health Policy 
Plan 2008;23:361–8.
 11 Lukes S. Power: a radical view. Second ed. Palgrave Macmillan, 
2005: 14–38.
 12 Gaventa J. Finding the spaces for change: a power analysis. IDS 
bull. , 2006: 37, 23–33. https://www. powercube. net/ wp- content/ 
uploads/ 2009/ 12/ finding_ spaces_ for_ change. pdf
 13 VeneKlasen L, Miller V. Power and Empowerment. In: A New Weave 
of Power, People & Politics: The Action Guide for Advocacy and 
Citizen Participation, 2002: 39–58. https:// justassociates. org/ sites/ 
justassociates. org/ files/ 07chap3_ power_ final. pdf
 14 Walt G. Health policy: an introduction to process and power. 
London; New Jersey: Zed Books, 1994: 153–77.
 15 Hyder A, Syed S, Puvanachandra P, et al. Stakeholder analysis 
for health research: case studies from low- and middle- income 
countries. Public Health 2010;124:159–66.
 16 Engel R, Schutt R. Chapter 4: Conceptualization and Measurement. 
In: Fundamentals of social work research, 2014: 67–71. https:// us. 
sagepub. com/ sites/ default/ files/ upm- assets/ 61666_ book_ item_ 
61666. pdf
12 Balane MA, et al. BMJ Global Health 2020;5:e002661. doi:10.1136/bmjgh-2020-002661
BMJ Global Health
 17 Palafox B, Seguin ML, McKee M, et al. Responsive and equitable 
health Systems- Partnership on non- communicable diseases 
(respond) study: a mixed- methods, longitudinal, observational 
study on treatment seeking for hypertension in Malaysia and the 
Philippines. BMJ Open 2018;8:e024000.
 18 Department of Health Philippines. Administrative Order No. 
2012-0029: Implementing guidelines on the institutionalization of 
Philippine Package of Essential NCD Interventions (Phil Pen) on the 
integrated management of hypertension and diabetes for primary 
health care facilities, 2012. Available: https:// dmas. doh. gov. ph: 8083/ 
Rest/ GetFile? id= 336917
 19 Arksey H, O'Malley L. Scoping studies: towards a methodological 
framework. Int J Soc Res Methodol 2005;8:19–32.
 20 Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping 
reviews (PRISMA- ScR): checklist and explanation. Ann Intern Med 
2018;169:467.
 21 Khan MS, Meghani A, Liverani M, et al. How do external donors 
influence National health policy processes? experiences of domestic 
policy actors in Cambodia and Pakistan. Health Policy Plan 
2018;33:215–23.
 22 Walls H, Liverani M, Chheng K, et al. The many meanings of 
evidence: a comparative analysis of the forms and roles of evidence 
within three health policy processes in Cambodia. Health Res Policy 
Syst 2017;15:95.
 23 Dalglish SL, Surkan PJ, Diarra A, et al. Power and pro- poor policies: 
the case of iCCM in niger. Health Policy Plan 2015;30 Suppl 
2:ii84–94.
 24 Meyer MA, Booker JM. Eliciting and analyzing expert judgment: 
a practical guide. Society for industrial and applied mathematics, 
2001.
 25 Perera AH, Drew CA, Johnson CJ. Expert knowledge and its 
application in landscape ecology. Springer New York, 2011.
 26 Susskind LE, McKearnen S, Thomas- Lamar J. The consensus 
building Handbook: a comprehensive guide to reaching agreement. 
Sage publications, 1999.
 27 McMillan SS, King M, Tully MP. How to use the nominal group and 
Delphi techniques. Int J Clin Pharm 2016;38:655–62.
 28 Heydari M, Seyedin H, Jafari M, et al. Stakeholder analysis of Iran's 
health insurance system. J Educ Health Promot 2018;7:135.
 29 Durham J, Warner M, Phengsavanh A, et al. Stakeholder analysis 
of community distribution of misoprostol in Lao PDR: a qualitative 
study. PLoS One 2016;11:e0162154.
 30 Caniato M, Vaccari M, Visvanathan C, et al. Using social network 
and stakeholder analysis to help evaluate infectious waste 
management: a step towards a holistic assessment. Waste Manag 
2014;34:938–51.
 31 Haidari AM, Zaidi S, Gul R. Prospects for the sustainability of 
delivering the basic package of health services in Afghanistan: a 
stakeholder analysis. 20, 2014. http:// applications. emro. who. int/ 
EMHJ/ V20/ 05/ EMHJ_ 2014_ 20_ 5_ 300_ 308. pdf
 32 Abiiro GA, McIntyre D. Universal financial protection through 
national health insurance: a stakeholder analysis of the proposed 
one- time premium payment policy in Ghana. Health Policy Plan 
2013;28:263–78.
 33 Ancker S, Rechel B. Hiv/Aids policy- making in Kyrgyzstan: a 
stakeholder analysis. Health Policy Plan 2015;30:8–18.
 34 Franco- Trigo L, Marqués- Sánchez P, Tudball J, et al. Collaborative 
health service planning: a stakeholder analysis with social network 
analysis to develop a community pharmacy service. Research in 
Social and Administrative Pharmacy 2020;16:216–29.
 35 Namazzi G, N KS, Peter W, et al. Stakeholder analysis for a maternal 
and newborn health project in eastern Uganda. BMC Pregnancy 
Childbirth 2013;13:58.
 36 Fischer SE, Strandberg- Larsen M. Power and Agenda- Setting in 
Tanzanian health policy: an analysis of Stakeholder perspectives. Int 
J Health Policy Manag 2016;5:355–63.
 37 Eden C, Ackermann F. Making strategy: the journey of strategic 
management. London: SAGE Publications Ltd, 1998: 113–35.
 38 Knai C, McKee M, Pudule I, et al. Soft drinks and obesity in Latvia: a 
stakeholder analysis. Eur J Public Health 2011;21:295–9.
 39 Gil A, Polikina O, Koroleva N, et al. Alcohol policy in a Russian 
region: a stakeholder analysis. Eur J Public Health 2010;20:588–94.
 40 Thomas S, Gilson L. Actor management in the development of 
health financing reform: health insurance in South Africa, 1994-1999. 
Health Policy Plan 2004;19:279–91.
 41 Kapilashrami A, McPake B. Transforming governance or reinforcing 
hierarchies and competition: examining the public and hidden 
transcripts of the global fund and HIV in India. Health Policy Plan 
2013;28:626–35.
 42 Varvasovszky Z, Brugha R. Stakeholder analysis: a review. Health 
Policy and Planning2000;15:338–45.
 43 Mitchell RK, Agle BR, Wood DJ. Toward a theory of Stakeholder 
identification and salience: defining the principle of who and what 
really counts. Acad Manage Rev 1997;22:853–86.
 44 Reyes- Alcázar V, Casas- Delgado M, Herrera- Usagre M, et al. 
Stakeholder analysis. Health Care Manag 2012;31:365–74.
 45 Bressers H, Klok P- J, O'Toole L. Explaining policy action: a 
deductive but realistic theory. Available: http:// citeseerx. ist. psu. 
edu/ viewdoc/ download? doi= 10. 1. 1. 534. 1901& rep= rep1& type= pdf 
[Accessed July 12 2019].
 46 Schang L, Thomson S, Czypionka T. Explaining differences in 
stakeholder take up of disease management programmes: a 
comparative analysis of policy implementation in Austria and 
Germany. Health Policy 2016;120:281–92.
 47 Bryson JM, Patton MQ, Bowman RA. Working with evaluation 
stakeholders: a rationale, step- wise approach and toolkit. Eval 
Program Plann 2011;34:1–12.
 48 Behzadifar M, Gorji HA, Rezapour A, et al. Hepatitis C virus- related 
policy- making in Iran: a stakeholder and social network analysis. 
Health Res Policy Syst 2019;17.
 49 Owens KA. Understanding how actors influence policy 
implementation, 2008. Available: https:// ris. utwente. nl/ ws/ 
portalfiles/ portal/ 6084898/ thesis_ Owens. pdf [Accessed July 12 
2019].
